March 30, 2020
market research

Deep Brain Stimulation Devices market is expanding at a CAGR of 11.6% from 2018 to 2026

The report includes forecast and analysis for the Deep Brain Stimulation Devices market on a global and regional level. The research gives important data of 2015, 2016 and 2017 along with a projection from 2018 to 2026 based on revenue. The study covers drivers and limitations of the Deep Brain Stimulation Devices market along with the impact they have on the trade over the forecast period. Additionally, the report covers the study of possibilities available in the Deep Brain Stimulation Devices market on a global level.

Leading Players:  Medtronic Plc, Boston Scientific Corporation, Abbott (St. Jude Medical, Inc.), Aleva Neurotherapeutics SA, NeuroPace, Inc., PINS Medical Co., Ltd.

Market Insight:

The global deep brain stimulation devices market was valued at US$ 699.6 Mn in 2017 and expected to reach US$ 1,889.4 Mn by 2026, expanding at a CAGR of 11.6% from 2018 to 2026.

Here you can get sample on this report:

Since the first application of deep brain stimulation (DBS) in the 1990s, the indications for the potential use of deep brain stimulation devices have been expanding. At present, over 1.5 million individuals have undergone DBS treatment for several approved and off label indications. Reversibility and titratability are the key features of deep brain stimulation devices augmenting their appeal in the field of clinical neurology. Despite their perceived advantages, the USFDA has been cautious in the approval and widespread adoption of deep brain stimulation treatments. Parkinson’s disease, epilepsy and tremors have been approved by the FDA with dystonia and obsessive compulsive disorders being granted exemption under humanitarian grounds. Conversely, the European commission is being more liberal in granting direct approval for these conditions. DBS has been applied for several conditions with proved benefits. However, due to scarcity of the number of procedures, robust evidence owing to difficulty in performing double blind randomized trials for such conditions is lacking.

As the global burden of neurological diseases is increasing, the healthcare infrastructure worldwide is augmenting its efforts towards introducing and incorporating new treatment methods and modalities that shall assist in mitigating the ever-growing toll of diseases. High morbidity has therefore created clinical urgency for long-term treatment options such as deep brain stimulation. Deep brain stimulation devices have proven evidence to have an important role in offering potential treatment to conditions such as epilepsy, tremors, and Parkinson’s disease, and are being further explored for their viability in other neurological areas.

Here you can get sample on this report:

The report aims to present a study of Global Deep Brain Stimulation Devices Market along with accurate segmentation of market by type, solution, application and five major geographical regions. Global Deep Brain Stimulation Devices market is supposed to witness a high increase during the forecast years due to expanding risk of data theft and firm government regulation.

The report also tracks the major market functions including product launches, technological advancements, mergers & benefits, and the innovative market tactics opted by key market players. Along with strategically examining the key micro markets, the paper also focuses on industry-specific drivers, restraints, possibilities and challenges in the Deep Brain Stimulation Devices market.

The objectives of this report are as follows:

-To present overview of the global Deep Brain Stimulation Devices market

-To examine and forecast the global Deep Brain Stimulation Devices market on the basis of types, explications, and applications
To present market size and forecast till 2026 for overall Deep Brain Stimulation Devices market with respect to five major regions, namely; North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and South America (SAM), which are later sub-segmented over respective major countries

-To evaluate market dynamics effecting the market during the projection period i.e., drivers, barriers, opportunities, and coming trend

-To provide exhaustive PEST analysis for all five regions

-To profiles key Deep Brain Stimulation Devices players influencing the industry along with their SWOT analysis and market policies

Here you can get sample on this report:

Study methodology

The research methodology for Credence Research’s Deep Brain Stimulation Devices market report utilizes a key of top-down and bottom-up research arrangements. Our initial focus on continuous market tracking, accurate fact-checking, data-triangulation, and multiple layers of quality control assures high-quality data that can be leveraged for actionable study insights.

Business segmentation

This report examines the Deep Brain Stimulation Devices market by the following segments:

•    Deep Brain Stimulation Devices Market, by Application

•    Deep Brain Stimulation Devices Market, By Technology

•    Deep Brain Stimulation Devices Market, By Portability

•    Deep Brain Stimulation Devices Market, By Type of Systems

•    Deep Brain Stimulation Devices Market, By End Users

•    Deep Brain Stimulation Devices Market, By Price Segments

Geographic coverage and Report

This market research report covers the following geographic regions in great detail:






Access Sample Copy Of this report


Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global DBSD Market Portraiture
2.2. Global DBSD Market, by Modality, 2017 (US$ Mn)
2.3. Global DBSD Market, by Application, 2017 (US$ Mn)
2.4. Global DBSD Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Deep Brain Stimulation Devices (DBSD) Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global DBSD Market, by Key Players, 2017

Chapter 4. Global Deep Brain Stimulation Devices (DBSD) Market, by Modality, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Subthalamic Nucleus (STN) DBS
4.3. Globus Pallidus Interna (GPi) DBS
4.4. Thalamus (Vim) DBS

Chapter 5. Global Deep Brain Stimulation Devices (DBSD) Market, by Application, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Parkinson’s Disease
5.3. Epilepsy
5.4. Obsessive Compulsive Disorder (OCD)
5.5. Dystonia
5.6. Essential Tremors

Chapter 6. Global Deep Brain Stimulation Devices (DBSD) Market, by Geography, 2016 – 2026 (US$ Mn)

Chapter 7. Company Profiles
7.1. Medtronic Plc
7.1.1. Business Description
7.1.2. Financial Information (Subject to Data Availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Boston Scientific Corporation
7.3. Abbott (St. Jude Medical, Inc.)
7.4. Aleva Neurotherapeutics SA
7.5. NeuroPace, Inc.
7.6. PINS Medical Co., Ltd.

………toc continued

Here you can get an updated sample on this report:

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals. Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.  Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

Contact Us:

Credence Research Inc.

105 N 1st ST #429


CA 95103

United States

Toll Free (US/CANADA): +1-800-361-8290


LinkedIn @

Leave a Reply

Your email address will not be published. Required fields are marked *